Research has shown that psychedelics such as psilocybin and ibogaine may be useful in the treatment of depression and anxiety, with statistically significant reductions in symptoms reported in around 80% of cases. This is a promising area of research as there are few alternatives in the pipeline and existing medications such as SSRIs are losing effectiveness over time.